Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
N/A
-4,812 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
N/A
-2,586 Reduced 34.96%
4,812 $17,000
Q3 2020

Nov 12, 2020

BUY
N/A
7,398 New
7,398 $15,000
Q4 2019

Feb 14, 2020

SELL
N/A
-1,213 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
N/A
1,213 New
1,213 $1,000
Q1 2019

May 14, 2019

SELL
N/A
-5,981 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
N/A
3,925 Added 190.9%
5,981 $6,000
Q3 2018

Nov 14, 2018

BUY
N/A
686 Added 50.07%
2,056 $4,000
Q2 2018

Aug 14, 2018

SELL
N/A
-2,560 Reduced 65.14%
1,370 $3,000
Q1 2018

May 15, 2018

BUY
N/A
3,930 New
3,930 $12,000
Q4 2017

Feb 14, 2018

SELL
N/A
-364 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
N/A
264 Added 264.0%
364 $1,000
Q1 2017

Nov 14, 2017

BUY
N/A
100
100 $0

About Cytocom, Inc.


  • Ticker CBLI
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,468,900
  • Market Cap $49.1M
More about CBLI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.